ישראל - עברית - Ministry of Health

abic marketing ltd, israel - phospholipids fraction from porcine lung - תרחיף - phospholipids fraction from porcine lung 80 mg/ml - lung surfactants - treatment of preterm babies with respiratory distress syndrome (rds). prophylactic use in premature infants at high risk of rds.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - calfactant as phospholipid - תרחיף - calfactant as phospholipid 35 mg/ml - lung surfactants - infasurf is indicated for the prevention of respiratory distress syndrome (rds) in premature infants at high risk for rds and for the treatment ("rescue") of premature infants who develop rds. infasurf decreases the incidence of rds mortality due to rds and air leaks associated with rds. prophylaxis : prophylaxis therapy at birth with infasurf is indicated for premature infants <29 weeks of gestational age at significant risk for rds. infasurf prophylaxis should be administered as soon as possible preferably within 30 minutes after birth. treatment: infasurf therapy is indicated for infants 72 hours of age with rds (confirmed by clinical and radiologic findings) and requiring endotracheal intubation.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - ethinylestradiol; norelgestromin - מדבקות - norelgestromin 6 mg; ethinylestradiol 0.6 mg - norelgestromin and estrogen - norelgestromin and estrogen - female contraception. evra is intended for women of fertile age.

ישראל - עברית - Ministry of Health

medison pharma ltd - edoxaban as tosylate - טבליות מצופות פילם - edoxaban as tosylate 15 mg - edoxaban

ישראל - עברית - Ministry of Health

medison pharma ltd - edoxaban as tosylate - טבליות מצופות פילם - edoxaban as tosylate 30 mg - edoxaban

ישראל - עברית - Ministry of Health

medison pharma ltd - edoxaban as tosylate - טבליות מצופות פילם - edoxaban as tosylate 60 mg - edoxaban